| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.28 | 1e-09 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.62 | 2e-08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |